TrxR (EC 1

TrxR (EC 1.8.1.9) activity was assessed using the TrxR Assay Kit (Sigma) in cell lysates. antiapoptotic Bcl-2 (Physique 1C) and Bcl-xL (Physique 1C) molecules, and induced caspase 3 activation (supplemental Physique 1B) and DNA fragmentation (supplemental Physique 1C). AF K 858 reduced TrxR activity (Physique 1D) and induced the accumulation of ROS (Physique 1E), which was inhibited by the ROS scavenger N-acetyl-cysteine (NAC) (Physique 1E). NAC reverted apoptotic effects by AF (supplemental Physique 1D). == Physique 1. == Antitumoral activity of AF in cHL.A panel of human cHL-derived cell lines (L-1236, L-428, KM-H2, HDLM-2, and L-540) were obtained from an authenticated source (DSMZ, German collection of microorganisms and cell cultures, Germany) and cultured in RPMI medium supplemented with 10% fetal calf serum (FCS). (A) cHL cells (2.0 105cells/mL) were treated for 24 or 48 hours with increasing concentrations of AF (Sigma) (0.1 to 10 M), for 48 hours with gemcitabine (Actavis) (1 to 500 nM), and for 72 hours with brentuximab (Takeda) (1 to 500 g/mL), and then viable cells were evaluated by trypan blue dye exclusion assay. Histograms show the 50% inhibitory concentration (IC50) values calculated using the CalcuSyn software (Biosoft). AF concentration (IC25, IC50, IC75and IC90, the drug concentration required for 25, 50, 75 and 90% growth inhibition in vitro) used in all experiments referred to the dose response obtained K 858 after 48 hours incubation with the drug (seeFigure 1A). (B) (2.0 105/mL) cHL cells were treated for 24 hours with AF IC75and then changes in the mitochondrial membrane potential were evaluated using the Mito-Tracker Reddish CMXRos (Invitrogen) by flow cytometry. Mitochondrial cytochrome-c (cyt-c) release was assessed on permeabilized and fixed cells. After washing twice with phosphate-buffered saline (to eliminate cyt-c in the cytoplasm), the residual cyt-c was detected using the mouse anticyt-c antibody (Becton-Dickinson [BD]) followed by phycoerythrin (PE)-conjugated goat anti-mouse immunoglobulins (IgG) (BD). (C) K 858 Bcl-2 associated X protein (BAX), B-cell lymphoma/leukemia-2 protein (Bcl-2), and B-cell lymphoma-extra large protein (Bcl-xL) were analyzed using anti-Bax K 858 generated from Bax- (BD), followed by PE-conjugated goat anti-mouse human IgG (BD), antiBcl-2-fluorescein isothiocyanate (FITC) (clone 124) (DAKO), and anti-human Bcl-xL (Cell Signaling) followed by goat anti-rabbit IgG-FITC (Jackson ImmunoResearch). Fluorescence-activated cell sorter (FACS) histograms are representative of 1 1 of 3 different experiments. Dotted lines show background fluorescence of cells, as determined by isotype-matched immunoglobulins (Ig). X- and Y-axes show the logarithms of the relative intensity of fluorescence and relative cell number, respectively. (D) Thioredoxin reductase (TrxR) activity was evaluated and expressed as enzyme unit per milligram of total protein (U/mg) in cHL cells (2.0 105/mL) treated for 24 hours with AF. TrxR (EC 1.8.1.9) activity was assessed using the TrxR Assay Kit (Sigma) in cell lysates. The relative activity was standardized by protein concentration using the protein assay dye reagent (Bio-Rad Laboratories). (E) Mitochondrial reactive oxygen species (ROS) production in the presence or absence of the antioxidantN-acetyl-cysteine (NAC; 5 mM) (Sigma) Rabbit Polyclonal to LMO4 was evaluated by circulation cytometry using MitoSox reagent (Molecular Probes). Results represent the imply standard error of the imply (SEM) of 3 replicate wells from 3 impartial experiments. (F). Nuclear factor B p65 transcription factor activity in nuclear extracts of cHL cells (2.0 105/mL) treated for 12 hours with AF was analyzed using the Transcription Factor Kit (p65) (Pierce Biotechnology). Values in the bar graph represent the mean SEM of 3 different experiments and standardized by protein concentration using the protein assay dye reagent (Bio-Rad Laboratories). (G) IRF4, CD40, CD30, discoidin domain name receptor 1 (DDR1), Notch1, and Jagged1 expression were evaluated in cHL cells incubated with AF for 12 hours by circulation cytometry using anti-IRF4 (M-17) (Santa Cruz Biotechnology), antiCD40-PE (BD), antiCD30-FITC (DAKO), anti-DDR1-PE (48B3) (Santa Cruz Biotechnology), antiNotch1-PE (R&D System), and anti-Jagged1 (J1G53-3) (AdipoGen) antibodies. Histograms symbolize the imply fluorescence intensity. (H) (2.0 105/mL) L-540 cells.